0001236031-18-000019.txt : 20180503 0001236031-18-000019.hdr.sgml : 20180503 20180503164106 ACCESSION NUMBER: 0001236031-18-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180501 FILED AS OF DATE: 20180503 DATE AS OF CHANGE: 20180503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZIMMERMAN DANIEL H CENTRAL INDEX KEY: 0001236028 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 18804458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-05-01 0 0000725363 CEL SCI CORP CVM 0001236028 ZIMMERMAN DANIEL H 0 1 0 0 Senior Vice President Options 2.45 2018-05-01 4 A 0 26194 0.01 A 2028-04-30 Common Stock 26194 72694 D Options 2.45 2018-05-01 4 A 0 100000 0.01 A 2028-04-30 Common Stock 100000 172694 D The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred. The stock options vest in three (3) equal annual installments commencing one year after the grant date. Dan Zimmerman 2018-05-03